Rep. Porter Honored For Work on Budget
WASHINGTON--Representative John Edward Porter of Illinois has received an American Academy of Otolaryngology--Head and Neck Surgery, Inc. award for "superb legislative leadership for medical research."
WASHINGTON--Representative John Edward Porter of Illinois hasreceived an American Academy of Otolaryngology--Head and NeckSurgery, Inc. award for "superb legislative leadership formedical research."
Rep. Porter, in his first year as chairman of the House of Representative'sSubcommittee on Labor-HHS-Education and Other Related Agencies,succeeded in extricating medical research funding from the overallbudget battle, thus assuring continuation of medical researchat medical centers and universities throughout the country.
In presenting the award, Robert J. Ruben, MD, professor of pediatrics,Albert Einstein College of Medicine of the Yeshiva Universityand Montefiore Medical Center, New York City, said that Rep. Porter'sleadership "allows vital research work . . . to go forwarduninterrupted . . . not only in our field, but also in the fieldsof cancer, heart disease, and lung disease--indeed in all healthareas of profound interest to the American people, and peopleworldwide."
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
